PumaBiotech (@pumabiotech) / X
Puma Biotechnology's NERLYNX® Included in Two Important NCCN Clinical Practice Guideline Updates for the Treatment of Breast Cancer | Business Wire
Donate to POGO - 2024 PUMA Toronto Women's 8K/5K — Race Roster — Registration, Marketing, Fundraising
Puma (E2P7G) Rabbit mAb | Cell Signaling Technology
Zatul (Iffa) Hughes MSN,RN,NE-BC - Clinical Nurse Educator - Puma Biotechnology, Inc. | LinkedIn
Puma Bio (PBYI) Restricting Access to Breast Cancer Event at ASCO 2015 - TheStreet
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug - TheStreet
FLASCO / Ask The Experts: HER2+ Breast Cancer Series – Jacksonville
Puma pounces on failed Takeda drug, snapping up cancer prospect
Jennifer Pylman - Senior Clinical Specialist lll - Puma Biotechnology, Inc. | LinkedIn
Kristie Traverso - Director Medical Engagement Stratagies at Puma Biotechnology | The Org
Southern New Hampshire Oncology Nurses - UPDATE INFO: Please join SNHON and Puma Biotechnology for the first webinar on Management Strategies for Reducing the Risk of Recurrence in HER2+ Breast Cancer Amal
PUMA Study | College of Medicine | MUSC
Puma Antibody | Cell Signaling Technology
Puma Biotech punts near $300 million on Takeda discard
PumaBiotech (@pumabiotech) / X
Caligor supporting Puma's expanded access program
Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks
Puma's Nerlynx unleashed to fight HER2+ breast cancer with 'best case' label | Fierce Pharma
David von Kleeck - Senior Clinical Specialist - Puma Biotechnology, Inc. | LinkedIn
PumaBiotech (@pumabiotech) / X
Puma Biotech's Breast Cancer Drug Results Mint New Billionaire Overnight
Puma Biotechnology unveils Phase II breast cancer trial design
